$1.28
-3.76%
N/A-$0.05
Healthcare
Biotechnology
NASDAQ
활발히 거래 중
Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, ...
Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, ...
C-레벨 임원은 회사의 재무 전략과 혁신을 이끄는 응집된 리더십 팀입니다.
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
| Quang X. Pham | Chairman & Chief Executive Officer | USD 1,062,029 | 1965 | Active | |
| James J. Ferguson FACC | Chief Medical Officer | USD 616,889 | — | 1954 | Active |
| Jeffrey Cole | Chief Operating Officer | USD 615,361 | 1968 | Active | |
| John Sharp | Interim CFO & Principal Accounting Officer | — | 1965 | Active | |
| Matthew Boxer | Executive Vice President of Corporate Development | — | — | — | Active |
| Filing Date | Year | Name | Position | Level | Salary | Bonus | Stock Award | Option Award | Incentive | Other | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-03 | 2025 | Quang X. Pham | Chief Chief Executive Officer | Founder / CEO | $751.27K | $296.75K | $0 | $847.66K | $0 | $14.00K | $1.91M |
| 2026-08-03 | 2025 | James J. Ferguson | Former Former Chief Chief Medical Officer | C-Level | $457.41K | $136.35K | $0 | $778.92K | $0 | $23.13K | $1.40M |
| 2026-08-03 | 2025 | Matthew Szot | Former Former Chief Chief Financial Officer | C-Level | $459.72K | $181.59K | $0 | $652.05K | $0 | $13.66K | $1.31M |
| 2026-08-03 | 2024 | Quang X. Pham | Chief Chief Executive Officer | Founder / CEO | $708.75K | $407.53K | $0 | $93.30K | $0 | $13.80K | $1.22M |
| 2026-08-03 | 2024 | Matthew Szot | Former Former Chief Chief Financial Officer | C-Level | $435.85K | $263.13K | $0 | $155.50K | $0 | $13.80K | $868.28K |
Sum of disclosed compensation by year (USD million)
Top founder/C-level executives over time (USD million)